Abnova (Taiwan) Corporation (TPE:4133)
Taiwan · Delayed Price · Currency is TWD 21.15
+0.15 (0.71%)
Aug 4, 2026, 1:30 PM CST
Abnova (Taiwan) Market Cap
Abnova (Taiwan) has a market cap or net worth of 1.27 billion as of August 4, 2026. Its market cap has decreased by -24.87% in one year.
Market Cap
1.27B
Enterprise Value
895.45M
Revenue
348.71M
Ranking
n/a
PE Ratio
662.31
Stock Price
21.15
ChartMarket Cap Chart
Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.27B, a decrease of -56.29%. That is a compound annual growth rate of -4.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.27B | -7.49% |
| Dec 31, 2025 | 1.37B | -23.44% |
| Dec 31, 2024 | 1.80B | -15.53% |
| Dec 29, 2023 | 2.13B | -14.81% |
| Dec 30, 2022 | 2.49B | -5.40% |
| Dec 30, 2021 | 2.64B | -25.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anti-Microbial Savior BioteQ | 1.56B |
| TaiRx | 1.48B |
| Andros Pharmaceuticals Co.,Ltd | 1.45B |
| GenMont Biotech Incorporation | 1.42B |
| Advagene Biopharma | 1.39B |
| NeoCore Technology | 1.35B |
| Enimmune | 1.13B |
| BiOptic | 1.12B |